Jose M. Carballido
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Assessment of antigen-specific T cell recall responses in non-human primates using a composite AIM assay.
Journal: Frontiers in immunology
Published: July 07, 2025
Granulysin Antimicrobial Activity Promotes Dormancy in Mycobacterium tuberculosis.
Journal: European journal of immunology
Published: October 30, 2024
Innate acting memory Th1 cells modulate heterologous diseases.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 05, 2024
Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.
Journal: Nature biomedical engineering
Published: November 05, 2021
Effect of ofatumumab on pregnancy, parturition, and lactation in cynomolgus monkeys.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: October 19, 2021
Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes.
Journal: Frontiers in immunology
Published: June 24, 2021
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
Journal: Pharmacology & therapeutics
Published: April 01, 2021
Mass Cytometry of CSF Identifies an MS-Associated B-cell Population.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 19, 2020
The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases.
Journal: Frontiers in immunology
Published: December 15, 2019
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.
Journal: Nature biomedical engineering
Published: December 05, 2019
Last Updated: 09/26/2026